CVS Health Corp

Análisis de la acción CVS Health Corp (CVS)

$93.470

-1.000 (-1.07%)Al cierre

Loading chart…
Máximo
94.400
Apertura
94.000
Precio medio ponderado por volumen
93.70
Volumen
4.60M
Capitalización
73.26B
Mínimo
93.215
Importe
431.17M
EV/EBITDA, TTM
8.80

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

cvshealth.com

Análisis de IA of CVS Health Corp (CVS)

Comprar

CVS Health Corp is a good buy right now, trading at $92.36 with a forward P/E of 10.67, indicating it is undervalued compared to its earnings potential. The stock has shown a strong 5-day change of +7.20%, reflecting positive momentum. However, the main risk is the recent downgrade in earnings guidance, which could impact future performance, as indicated by the EPS guidance revision to $6.53-$6.75.

Métricas de valoración

El PER previsto actual de CVS Health Corp (CVS) es 10.67, frente a su media de 5 años de 10.51.

PER previsto

Valor razonable
Media 5A P/E
10.51
P/E actual
10.67
Sobrevalorada
12.12
Infravalorada
8.89

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
10.29
EV/EBITDA actual
8.80
Sobrevalorada
14.75
Infravalorada
5.83

Precio/ventas previsto

Valor razonable
Media 5A P/S
0.28
P/S actual
0.28
Sobrevalorada
0.36
Infravalorada
0.20

Escenarios de precio de Alphio AI para CVS

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%CVS

$66.08

Precio del escenario

B

Base

Base · 50%CVS

$55.76

Precio del escenario

B

Bajista

Bajista · 25%CVS

$44.79

Precio del escenario

Ballenas con CVS en cartera

T

Turtle Creek Management, LLC

+ Con en carteraCVS

+17.12%

Rentabilidad a 3 meses

H

Hotchkis and Wiley Capital Management, LLC

+ Con en carteraCVS

+9.79%

Rentabilidad a 3 meses

G

GQG Partners, LLC

+ Con en carteraCVS

+9.35%

Rentabilidad a 3 meses

S

Scharf Investments, LLC

+ Con en carteraCVS

+7.39%

Rentabilidad a 3 meses

N

Nippon Life Global Investors Americas, Inc.

+ Con en carteraCVS

+5.66%

Rentabilidad a 3 meses

C

CX Institutional, LLC

+ Con en carteraCVS

+5.18%

Rentabilidad a 3 meses

Preguntas frecuentes sobre CVS, respondidas por Alphio AI

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. It operates in the Healthcare sector (RETAIL-DRUG STORES AND PROPRIETARY STORES industry).

CVS Health Corp is a good buy right now, trading at $92.36 with a forward P/E of 10.67, indicating it is undervalued compared to its earnings potential. The stock has shown a strong 5-day change of +7.20%, reflecting positive momentum. However, the main risk is the recent downgrade in earnings guidance, which could impact future performance, as indicated by the EPS guidance revision to $6.53-$6.75.

Comunidad

Más ↗
0xSkewfalcon5/10/2026

PeloSwing Weekly Watchlist 👀 $CVS $PEP If you found this watchlist useful, make sure to turn notifications on for more! You don’t want to miss our posts throughout the day!🔔 Let’s have an amazing week! 💰

Mostrar más
Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar